不同报告时间结核分枝杆菌药物敏感性试验结果不一致的原因

doi:10.3969/j.issn.1000-6621.2014.10.003

中国防痨杂志 ›› 2014, Vol. 36 ›› Issue (10): 874-879.doi: 10.3969/j.issn.1000-6621.2014.10.003

不同报告时间结核分枝杆菌药物敏感性试验结果不一致的原因

谷蕴婷于霞李云絮赵立平王桂荣陈素婷黄海荣

101149 首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所国家结核病临床实验室

收稿日期:2014-04-17 出版日期:2014-10-10 发布日期:2014-11-01
通信作者: 黄海荣 E-mail:hairong.huangcn@gmail.com
基金资助:
北京市重大科技攻关项目（D121100003012001）

The cause analysis of the inconsistency in the outcomes of drug susceptibility test for Mycobacterium tuberculosis by different report time

GU Yun-ting, YU Xia, LI Yun-xu, ZHAO Li-pin, WANG Gui-rong, CHEN Su-ting, HUANG Hai-rong

Beijing Chest Hospital, Capital Medical University,Beijing Tuberculosis and Thoracic Tumor Institute,National Clinical Laboratory on Tuberculosis, Beijing 101149, China

Received:2014-04-17 Online:2014-10-10 Published:2014-11-01
Contact: HUANG Hai-rong E-mail:hairong.huangcn@gmail.com

摘要/Abstract

摘要： 目的探讨和分析使用绝对浓度法药物敏感性试验（简称“药敏试验”）时不同报告时间结果不一致的原因。方法 2010年1—6月笔者收集采用绝对浓度法于37℃含INH的L-J培养基上培养4周时无菌落生长、时间延长至6周后才生长的13株菌株（含药培养基延迟生长菌株）。这些菌株来源于11例结核病患者（2例患者的菌株在低浓度和高浓度INH时均有菌落生长）；同时收集这11例结核病患者的临床敏感株作为对照菌株，共计24株菌株。进行比例法药敏试验和PCR菌种鉴定，并利用分枝杆菌散在分布重复单位（Mycobacterium interspersed repetitive unit，MIRU）和结核分枝杆菌间隔区寡核苷酸分型(spoligotyping)技术进行基因分型，并选择对照菌株和含药培养基延迟生长菌株MRIU分型不同的3株菌株进行人工模拟不同浓度INH时混合的敏感菌株和耐药菌株进行绝对浓度法药敏试验，观察不同报告时间（4周和6周）的药敏试验结果。结果 24株菌株经PCR鉴定均为结核分枝杆菌复合群。比例法药敏试验中 13株含药培养基延迟生长菌株均对INH耐药，11株对照菌株均对INH敏感。3例患者的对照菌株和含药培养基延迟生长菌株Spoligotying分型属于不同型别，分别为北京基因型和T2型、北京基因型和H3型、北京基因型和T2型。人工混合感染的3株菌株比例 (临床株:H37Rv)小于1：128 时可能会出现4周无菌落生长而6周有菌落生长的结果。结论对药物敏感性不同的结核分枝杆菌造成的混合感染，当耐药菌株的比例较低时，可能造成不同报告时间药敏试验结果不一致的情况。

关键词: 分枝杆菌, 结核, 微生物敏感性试验, 偏差

Abstract: Objective To determine when the susceptibility of the colony forming on the slants performed by absolute concentration method the cause analysis of the inconsistency in the outcomes of drug susceptibility test for Mycobacterium tuberculosis by different report time. Methods Thirteen isolates on the INH containing medium from 11 patients with colony forming after six weeks were collected and the strains on the drug free L-J medium were also collected.All 24 collected strains were performed PCR species identification, MIRU and spoligotying gene typing, drug susceptibility tests (DST), INH resistant gene and randomly selected 3 strains （7019H0.2,7285H0.2 and 7325H1）to do DST for Simulation mixed population of INH susceptible and resistant strains.Observe the results in differert report time (4 and 6 weeks). All the patients were recived telephone follow-up about treatment and drug resistance results. Results All 13 isolates from INH contain medium were INH resistant when the proportion method was performed after subculture while all 11 strains from drug free medium were all INH susceptible.All the 13 isolates from INH containing medium and 11 isolates from control medium were identified as Mycobacterium tuberculosis complex (MtbC). Of 13 isolates from INH resistant strains, 10 strains (10/13,76.92%)had mutation in the katG gene (S315T). Among the 11 patients, 3 patients were proved to be INH resistant in the following DST.Three patients owned the different genotype between the drug containing medium and control medium.The genetype were Beijing and T2,Beijing and H3, Beijing and T2.Three strains mixed with H37Rv grown after 6 weeks instead of 4 weeks when the proportion was less than 1;128 (clinical isolate:H37Rv). Conclusion Case of mixed infection of different drug sensitivity caused by Mycobacterium tuberculosis, when the proportion of resistant strains is low,it may cause inconsistent results in different report time.

Key words: Mycobacterium tuberculosis, Microbial sensitivity tests, Uncertainty

谷蕴婷，于霞，李云絮，赵立平，王桂荣，陈素婷，黄海荣. 不同报告时间结核分枝杆菌药物敏感性试验结果不一致的原因[J]. 中国防痨杂志, 2014, 36(10): 874-879. doi: 10.3969/j.issn.1000-6621.2014.10.003

GU Yun-ting, YU Xia, LI Yun-xu, ZHAO Li-pin, WANG Gui-rong, CHEN Su-ting, HUANG Hai-rong. The cause analysis of the inconsistency in the outcomes of drug susceptibility test for Mycobacterium tuberculosis by different report time[J]. Chinese Journal of Antituberculosis, 2014, 36(10): 874-879. doi: 10.3969/j.issn.1000-6621.2014.10.003

参考文献

［1］中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南（2008年版）.北京：中国协和医科大学出版社,2009: 1.
［2］World Health Organization.Policy guidance on drug-susceptibility testing (DST) of second-line anti-tuberculosis drugs. Geneva：World Health Organization，2008.
［3］Kim SJ, Espinal MA, Abe C,et al. Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuber Lung Dis, 2004,8(9):1157-1158.
［4］Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis,2008, 21(6)：587-595.
［5］Abed Y, Davin-Regli A, Bollet C, et al.Efficient discrimination of Mycobacterium tuberculosis strains by 16S-23S spacer region-based random amplified polymorphic DNA analysis.J Clin Microbiol,1995,33(5):1418-1420.
［6］Roth A, Fischer M, Hamid ME, et al.Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences.J Clin Microbiol,1998,36(1):139-147.
［7］Sansila A, Hongmanee P, Chuchottaworn C, et al.Differentiation between Mycobacterium tuberculosis and Mycobacterium avium by amplification of the 16S-23S ribosomal DNA spacer. J Clin Microbiol,1998,36(9):2399-2403.
［8］赵立平,于霞,姜广路, 等. 对BACTETTM MGIT960培养报告结果为阴性的培养管中颗粒性物质的研究. 中国防痨杂志，2013,35(1):28-32.
［9］Pang Y, Zhou Y, Zhao B,et al. Spoligotyping and drug resis-tance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One, 2012,7(3):e32976.
［10］逄宇，夏辉，姜广路，等.中国结核分枝杆菌寡核苷酸基因分型及其耐药性分析.中华检验医学杂志，2011, 34（11）:1023-1028.
［11］Cowan LS, Diem L, Monson T,et al. Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the united States. J Clin Microbiol, 2005,43(2):688-695.
［12］Minime-Lingoupou F, Pierre-Audigier C, Kassa-Kélémbho E, et al. Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic. Int J Tuberc Lung Dis, 2010,14(6):782-785.
［13］中国防痨协会基础专业委员会.结核病诊断实验室检验规程. 北京：中国教育文化出版社, 2006: 49-51.
［14］Zhao Y, Xu S, Wang L, et al. National survey of drug-resis-tant tuberculosis in China. N Engl J Med, 2012,366(23):2161-2170.
［15］Giampaglia CM, Martins MC, Chimara E,et al.Differentiation of Mycobacterium tuberculosis from other mycobacteria with P-nitrobenzoic acid using MGIT960. Int J Tuberc Lung Dis, 2007,11(7):803-807.
［16］Parsons LM, Somoskovi A, Gutierrez C, et al. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev, 2011,24(2):314-350.
［17］Shen G, Xue Z, Shen X,et al. The study recurrent tuberculosis and exogenous reinfection, Shanghai, China. Emerg Infect Dis, 2006,12(11):1776-1778.
［18］Viveiros M, Portugal I, Bettencourt R, et al. Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother,2002,46(9):2804-2810.

[1]	张超, 于霞, 黄海荣, 刘伟, 刘涛. 七氟烷对结核分枝杆菌体外抑菌效果的评价[J]. 中国防痨杂志, 2025, 47(2): 158-163.
[2]	王健华, 史坤雄, 黄雅欣, 梁葵弟, 梁汉成. GeneXpert MTB/RIF对快速诊断肺结核及检测利福平耐药性的价值分析[J]. 中国防痨杂志, 2024, 46(S1): 94-96.
[3]	陈双双, 田丽丽, 王嫩寒, 杨新宇, 赵琰枫, 李传友, 代小伟. 17种抗生素对北京地区快速生长分枝杆菌体外抑菌效果分析[J]. 中国防痨杂志, 2024, 46(9): 1056-1062.
[4]	于兰, 陈双双, 王嫩寒, 田丽丽, 赵琰枫, 樊瑞芳, 刘海灿, 李传友, 代小伟. 利福平耐药结核分枝杆菌对氟喹诺酮类药物表型耐药与其基因突变的一致性研究[J]. 中国防痨杂志, 2024, 46(8): 942-950.
[5]	程梦丽, 姜广路, 霍凤敏, 薛毅, 于霞. 夫西地酸对分枝杆菌的体外抑菌效果评价[J]. 中国防痨杂志, 2024, 46(4): 461-466.
[6]	裴少君, 欧喜超. 世界卫生组织《结核分枝杆菌耐药相关基因突变目录(第2版)》解读[J]. 中国防痨杂志, 2024, 46(3): 260-266.
[7]	李静, 姜琦, 江渊, 沈鑫. PCR荧光探针技术对结核分枝杆菌复合群及利福平耐药性检测性能的评价[J]. 中国防痨杂志, 2024, 46(10): 1250-1258.
[8]	宋媛媛, 夏辉, 赵雁林. 结核分枝杆菌表型药物敏感性试验临界浓度设定发展历程[J]. 中国防痨杂志, 2023, 45(7): 631-638.
[9]	朱玉梅, 夏子涵, 李金莉, 何慧珊, 王峰. 多色探针熔解曲线分析技术检测准广泛耐药肺结核的应用价值[J]. 中国防痨杂志, 2023, 45(4): 406-411.
[10]	王潮虹, 孙晴, 廖鑫磊, 晏君, 王晨倩, 姜广路, 王芬, 薛毅, 黄海荣, 王桂荣. 231例脊柱结核患者耐药情况分析[J]. 中国防痨杂志, 2022, 44(9): 940-946.
[11]	夏辉, 郑扬, 宋媛媛. 世界卫生组织《优化肉汤微孔板法结核分枝杆菌复合群药物敏感性试验方法学》解读[J]. 中国防痨杂志, 2022, 44(7): 641-645.
[12]	王少华, 赵国连, 王佩, 谈小文, 崔晓利, 康磊, 党丽云. 结核分枝杆菌利福平基因型药敏和表型药敏检测结果不一致原因分析[J]. 中国防痨杂志, 2022, 44(2): 169-173.
[13]	于霞, 任汝颜, 文舒安, 梁倩, 董玲玲, 黄海荣. 13种抗生素对快生长分枝杆菌的体外抑菌效果评价[J]. 中国防痨杂志, 2021, 43(9): 947-951.
[14]	易俊莉, 杨新宇, 陈昊, 赵琰枫, 陈双双, 张洁, 丁北川, 代小伟, 孙闪华, 武文清, 李传友. 1156株结核分枝杆菌临床分离株耐药情况分析[J]. 中国防痨杂志, 2021, 43(7): 677-681.
[15]	王璐, 薛仲探, 王玉峰, 尚媛媛, 任卫聪, 姚丛, 高飞, 逄宇. 结核分枝杆菌对贝达喹啉药物敏感性动态监测及耐药制研究[J]. 中国防痨杂志, 2021, 43(5): 482-486.

不同报告时间结核分枝杆菌药物敏感性试验结果不一致的原因

The cause analysis of the inconsistency in the outcomes of drug susceptibility test for Mycobacterium tuberculosis by different report time

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

友情链接